Tag: Mr. Adarsh Munjal

Remedium Lifecare’s Rights Issue – A Promising Bet in Pharma

Mumbai, April 29, 2025: Remedium Lifecare Limited has announced the launch of its much-anticipated Rights Issue, which has received approval from the Bombay Stock Exchange (BSE). This strategic initiative marks a significant step in the company’s journey toward becoming a vertically integrated, research-driven pharmaceutical leader. The Rights Issue will open on April 30, 2025, and close […]